High temporal resolution systems profiling reveals distinct patterns of interferon response after Covid-19 mRNA vaccination and SARS-CoV2 infection
Author:
Rinchai DarawanORCID, Deola Sara, Zoppoli Gabriele, Ahamed Kabeer Basirudeen Syed, Taleb Sara, Pavlovski Igor, Maacha Selma, Gentilcore Giusy, Toufiq Mohammed, Mathew Lisa, Liu Li, Vempalli Fazulur Rehaman, Mubarak Ghada, Lorenz Stephan, Sivieri Irene, Cirmena Gabriella, Dentone Chiara, Cuccarolo Paola, Giacobbe Daniele Roberto, Baldi Federico, Garbarino Alberto, Cigolini Benedetta, Cremonesi Paolo, Bedognetti Michele, Ballestrero Alberto, Bassetti Matteo, Hejblum Boris P.ORCID, Augustine Tracy, Panhuys Nicholas Van, Thiebaut Rodolphe, Branco Ricardo, Chew Tracey, Shojaei Maryam, Short Kirsty, Feng Carl, Zughaier Susu M., Maria Andrea De, Tang Benjamin, Hssain Ali Ait, Bedognetti Davide, Grivel Jean-Charles, Chaussabel Damien,
Abstract
ABSTRACTKnowledge of the mechanisms underpinning the development of protective immunity conferred by mRNA vaccines is fragmentary. Here we investigated responses to COVID-19 mRNA vaccination via ultra-low-volume sampling and high-temporal-resolution transcriptome profiling (23 subjects across 22 timepoints, and with 117 COVID-19 patients used as comparators). There were marked differences in the timing and amplitude of the responses to the priming and booster doses. Notably, we identified two distinct interferon signatures. The first signature (A28/S1) was robustly induced both post-prime and post-boost and in both cases correlated with the subsequent development of antibody responses. In contrast, the second interferon signature (A28/S2) was robustly induced only post-boost, where it coincided with a transient inflammation peak. In COVID19 patients, a distinct phenotype dominated by A28/S2 was associated with longer duration of intensive care. In summary, high-temporal-resolution transcriptomic permitted the identification of post- vaccination phenotypes that are determinants of the course of COVID-19 disease.
Publisher
Cold Spring Harbor Laboratory
Reference35 articles.
1. Tregoning JS , Flight KE , Higham SL , Wang Z , Pierce BF . Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021 Aug 9; 2. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses 3. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans 4. Systems vaccinology: Enabling rational vaccine design with systems biological approaches 5. Arunachalam PS , Scott MKD , Hagan T , Li C , Feng Y , Wimmers F , et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021 Jul 12;
|
|